A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
This is a non-randomized, phase II, open label study of apatinib mesylate tablets plus
tegafur gimeracil oteracil potassium capsules induction chemotherapy in locally advanced
squamous cell carcinoma of head and neck patients who were judged surgically unresectable or
appropriate for non-surgical definitive therapy.The primary purpose of this study is to
evaluate the efficacy of apatinib mesylate tablets plus tegafur gimeracil oteracil potassium
capsules in locally advanced squamous cell carcinoma of head and neck
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University